Literature DB >> 18715875

High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation.

P Sheen1, C M O'Kane, K Chaudhary, M Tovar, C Santillan, J Sosa, L Caviedes, R H Gilman, G Stamp, J S Friedland.   

Abstract

Tuberculosis (TB) pleural disease is complicated by extensive tissue destruction. Matrix metalloproteinase (MMP)-1 and -9 are implicated in immunopathology of pulmonary and central nervous system TB. There are few data on MMP activity in TB pleurisy. The present study investigated MMP-1, -2 and -9 and their specific inhibitors (tissue inhibitor of metalloproteinase (TIMP)-1 and -2) in tuberculous effusions, and correlated these with clinical and histopathological features. Clinical data, routine blood tests, and pleural fluid/biopsy material were obtained from 89 patients presenting with pleural effusions in a TB-endemic area. MMP-1, -2 and -9 were measured by zymography or western blot, and TIMP-1 and -2 by ELISA. Pleural biopsies were examined microscopically, cultured for acid-alcohol fast bacilli and immunostained for MMP-9. Tuberculous pleural effusions contained the highest concentrations of MMP-9 compared with malignant effusions or heart failure transudates. MMP-9 concentrations were highest in effusions from patients with granulomatous biopsies: median (interquartile range) 108 (61-218) pg x mL(-1) versus 43 (12-83) pg x mL(-1) in those with nongranulomatous pleural biopsies. MMP-1 and -2 were not upregulated in tuberculous pleural fluid. The ratio of MMP-9:TIMP-1 was significantly higher in TB effusions. Tuberculous pleurisy is characterised by a specific pattern of matrix metalloproteinase-9 upregulation, correlating with the presence of granulomas and suggesting a specific role for matrix metalloproteinase-9 in inflammatory responses in tuberculous pleural disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715875     DOI: 10.1183/09031936.00127807

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  29 in total

1.  Matrix metalloproteinase proteolysis of the mycobacterial HSP65 protein as a potential source of immunogenic peptides in human tuberculosis.

Authors:  Sergey A Shiryaev; Piotr Cieplak; Alexander E Aleshin; Qing Sun; Wenhong Zhu; Khatereh Motamedchaboki; Alexander Sloutsky; Alex Y Strongin
Journal:  FEBS J       Date:  2011-08-08       Impact factor: 5.542

2.  Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection.

Authors:  Sambasivan Venkatasubramanian; Deepak Tripathi; Torry Tucker; Padmaja Paidipally; Satyanarayana Cheekatla; Elwyn Welch; Anjana Raghunath; Ann Jeffers; Amy R Tvinnereim; Melissa E Schechter; Bruno B Andrade; Nizel Mackman; Steven Idell; Ramakrishna Vankayalapati
Journal:  Eur J Immunol       Date:  2015-11-10       Impact factor: 5.532

3.  Comparison of localized versus systemic levels of Matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients.

Authors:  Swetha Sundararajan; Subash Babu; Sulochana D Das
Journal:  Hum Immunol       Date:  2012-07-20       Impact factor: 2.850

4.  Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.

Authors:  Catherine W M Ong; Paul T Elkington; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

Review 5.  Immunity and Immunopathology in the Tuberculous Granuloma.

Authors:  Antonio J Pagán; Lalita Ramakrishnan
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-06       Impact factor: 6.915

6.  Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium.

Authors:  Hannah E Volkman; Tamara C Pozos; John Zheng; J Muse Davis; John F Rawls; Lalita Ramakrishnan
Journal:  Science       Date:  2009-12-10       Impact factor: 47.728

7.  High matrix metalloproteinase production correlates with immune activation and leukocyte migration in leprosy reactional lesions.

Authors:  Rosane M B Teles; Rose B Teles; Thais P Amadeu; Danielle F Moura; Leila Mendonça-Lima; Helen Ferreira; Italo M C F Santos; José A C Nery; Euzenir N Sarno; Elizabeth P Sampaio
Journal:  Infect Immun       Date:  2009-12-14       Impact factor: 3.441

8.  Mycobacterium bovis-BCG vaccination induces specific pulmonary transcriptome biosignatures in mice.

Authors:  Elihu Aranday Cortes; Daryan Kaveh; Javier Nunez-Garcia; Philip J Hogarth; H Martin Vordermeier
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

9.  The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts.

Authors:  Chuan-Chin Huang; Eric Tchetgen Tchetgen; Mercedes C Becerra; Ted Cohen; Katherine C Hughes; Zibiao Zhang; Roger Calderon; Rosa Yataco; Carmen Contreras; Jerome Galea; Leonid Lecca; Megan Murray
Journal:  Clin Infect Dis       Date:  2013-12-23       Impact factor: 9.079

10.  Profile of Metalloproteinases and Their Association with Inflammatory Markers in Pleural Effusions.

Authors:  Lisete Ribeiro Teixeira; Murilo B Dias; Roberta K B Sales; Leila Antonangelo; Vanessa A Alvarenga; Juliana Puka; Evaldo Marchi; Milena Marques Pagliarelli Acencio
Journal:  Lung       Date:  2016-09-27       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.